The Influence of Pharmaceutical Companies and Manipulation of Clinical Trial Outcomes

This chapter explores the role of pharmaceutical companies in shaping policies and manipulating clinical trial outcomes regarding the use of Ivermectin in the United States. The speakers discuss the paradox of high mortality rates despite well-funded medical care and the pressure faced by academics to conform to the established narrative.